Prevelance And Risk Factors for Hepatitis C Virus Infection in Hemodialysis Patients
DOI:
https://doi.org/10.52783/jns.v14.3622Keywords:
Hepatitis C, Hemodialysis, Prevalence, HCV seroconversion, blood transfusion.Abstract
Background: Hepatitis C virus (HCV) infections continue to remain a significant global health challenge due to its morbidity and mortality profile. Among individuals undergoing hemodialysis (HD), the incidence of HCV transmission is notably higher than in the general population. Aim: this study aimed to estimate the Seroprevalence of HCV infection and associated risk factors among patients undergoing hemodialysis in a tertiary care hospital. Materials and Methods: This cross-sectional observational study included 300 patients’ undergoing maintenance HD due to chronic kidney disease (CKD). Data collection involved demographic details, frequency of blood transfusion, duration of dialysis, duration of CKD, associated comorbidities, and other risk factors. All enrolled patients were screened for anti-HCV antibodies using an enzyme-linked immunosorbent assay (ELISA). Results: The prevalence of HCV was 13% among hemodialysis patients. The frequency of blood transfusion, duration of CKD, duration of hemodialysis, and not applied infection control measures were found to be significant risk factors for seroconversion. Family history of HCV infection, surgical procedures during the dialysis period, past history of surgery, temporary vascular Access, and HbsAg status were insignificant risk factors for HCV seroconversion. Conclusion: Frequent blood transfusion, longer duration of CKD, longer duration of hemodialysis and failure to applied infection control measures were significant risk factors for HCV seroconversion in dialysis patients
Downloads
Metrics
References
Ahmad J, Eng FJ, Branch AD. HCV and HCC: clinical update and a review of HCC-associated viral mutations in the core gene. Semin Liver Dis. 2011; 31(4):347-355. doi: 10.1055/s-0031-1297924
Nguyen DB, Bixler D, Patel PR. Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention. Semin Dial. 2019; 32:127-34. https://doi.org/10.1111/sdi.12761
World Health Organization. Hepatitis C. (2024). Accessed: Feb 01, 2025. Available from: https://www.who.int/newsroom/fact-sheets/detail/hepatitis-c.
Ozer Etik D, Ocal S, Boyacioglu AS (2015) Hepatitis C infection in hemodialysis patients: a review. World J Hepatol 7(6):885–895
Jakupi X, Mlakar J, Lunar MM, et al. A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study. BMC Nephrol. 2018; 19(1):304. doi: 10.1186/s12882-018-1100-5
Thurlow JS, Joshi M, Yan G, Norris KC, Agodoa LY, Yuan CM et al (2021) Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol 52(2):98–107
Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ (2012) Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine. The Lancet infectious diseases 12(5):408–414
Zamani F, Sohrabi M, Poustchi H, Keyvani H, Saeedian FS, Ajdarkosh H, Khoonsari M, Hemmasi G, Moradilakeh M, Motamed N (2013) Prevalence and risk factors of hepatitis C virus infection in Amol city, north of Iran: a population-based study (2008-2011). Hepatitis Monthly 13(12)
Duong MC, Nguyen VTT, Otsu S, McLaws ML. Prevalence of hepatitis B and C virus infections in hemodialysis patients in Vietnam: A systematic review and meta-analysis. JGH Open. 2019; 4(1):29-38. doi: 10.1002/jgh3.12199
Lavanchy D. The global burden of hepatitis C. Liver Int 2009; 29(s1): 74-81.
da Costa-Marques-Borges LF, Zalis MG, Santoro-Lopes G, Varella RB (2019) Hepatitis C virus genotypes in hemodialysis patients in Angola. J Med Virol 91(3):518–521
Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001; 50(Rr-5):1–43.
KDIGO 2018 Clinical Practice Guideline for the Prevention, Diag nosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl 2018; 8(3):91–165.
Kumar PS, Venu G, Rao AM, Balakrishnan N, SaraVanan T, Sofiarani A. Prevalence and risk factors of hepatitis C among maintenance hemo- dialysis patients at a tertiary care hospital in Coimbatore. India J Clin Diagnostic Res. 2011;5:725-728
Rajasekaran C, Kalpanaraj D, Banu ST, Duraivel M. Seroprevalence of Hepatitis C Virus Infection among Hemodialysis Patients in A Tertiary Care Hospital in South India. J Pure Appl Microbiol. 2023;17(1):371-379. doi: 10.22207/JPAM.17.1.27
Reddy AK, Murthy KV, Lakshmi V. Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection. Indian J Med Microbiol. 2005;23(2):106-10. doi: 10.4103/02550857.16049
Dhar A, Chandail VS, Samyal V, Jamwal V,. Prevalence of hepatitis C in patients with chronic kidney disease at a tertiary care hospital in north India: a retrospective analysis. Int J Res Med Sci. 2019;7:2198-203. doi: 10.18203/2320-6012.ijrms20192498
Jamil M, Bhattacharya PK, Yunus M, Lyngdoh CJ, Roy A, Talukdar KK. Prevalence of hepatitis B and hepatitis C in haemodialysis population in a tertiary care centre in north eastern India. Int J Biomed Amp Adv Res. 2016; 7:267-269. doi: 10.7439/ijbar.v7i6.3356
Kerollos Motwade N. Kerollos* , Hussein Ahmed El-Ameen, Lobna Abd El Wahed and Nashwa Mostafa A. Azoz, Prevalence and seroconversion of hepatitis C among hemodialysis patients in Assiut governorate, Egypt, The Egyptian Journal of Internal Medicine (2020) 32:2
H Hinrichsen, G Leimenstoll, G Stegen, H Schrader, U R Fölsch, W E Schmidt, Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients, Gut 2002;51:429–433
Khattab OS (2008) Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center. Saudi Journal of Kidney Diseases and Transplantation 19(1):110
Cristina Gómez-Gutiérrez,* Norberto C. Chávez-Tapia,* Guadalupe Ponciano-Rodríguez,** Misael Uribe,* Nahum Méndez-Sánchez, Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin America, Annals, of Hepatology, 2015; 14 (6): 807-814.
Alshebani TB, Alruwaili YM, Alruwaili MH, Alotaibi AN, Alshaybah FA, Alomran AY et al. Prevalence of hepatitis B and hepatitis C virus in haemodialysis patients. Int J Community Med Public Health 2023;10:342-5
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
